Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival - Wikidata - wikimedia - TriplyDB

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

http://www.wikidata.org/entity/Q36496601

about

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.Transplant outcomes in acute leukemia. I.Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.Hematopoietic stem cell transplantation for MDS.High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation.High-dose cyclophosphamide for graft-versus-host disease prevention.Selecting donor recipients.Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.Risk factors for acute GVHD and survival after hematopoietic cell transplantation Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.Evaluation of prognostic factors among patients with chronic graft-versus-host disease.Timeline, epidemiology, and risk factors for bacterial, fungal, and viral infections in children and adolescents after allogeneic hematopoietic stem cell transplantation.A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.The hematopoietic system in the context of regenerative medicine.A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Methods for equivalence and noninferiority testing.Peripheral-blood stem cells versus bone marrow from unrelated donors Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.Role of allogeneic transplantation in chronic myeloid leukemia.Current clinical management of Fanconi anemia.

P2860

Q24195048-01F71808-ED2C-4F8F-86E6-C85380D52DF5 Q30274942-7B643BB2-1D26-44FA-A489-B2F95269BA04 Q33621502-0758226E-0781-4390-8970-EBD59259C510 Q33685495-2E159709-3768-4B8A-BEA8-AF4BE99F8890 Q33767314-47B5E6B0-629F-4651-A279-9E2FFBF9589F Q33806054-29F1AC81-2F09-4A82-93A5-C318DD3A9802 Q33813439-9114FA36-04E8-4F92-92AA-FBE6097619B2 Q33822026-AEBF9E1E-8B9B-4FF2-9141-FD7BC592DC10 Q33941128-547E4CE7-99E4-421F-AF77-6C2EF48B7105 Q34033553-5F0CA2C9-534A-4BAC-BC6E-034C2ABDE5C4 Q34374133-BDF4E9F5-3331-4C6D-AB3F-CB1A254C96E7 Q34707280-8758382D-CDF8-457E-B92C-BBDDC2C1C624 Q34770016-D12CB66A-C76F-4D2E-88E2-E49096B9736B Q34996663-77AB6F3F-CB66-4734-8746-A740BB9B377C Q35042790-5CACD5DA-5377-4C5E-B508-F72D6903C464 Q35042830-E95B8599-C70C-416D-8CF0-39EADD702B71 Q35067642-30FD602D-08C8-474B-8229-1445C31AD246 Q35103562-0B3FCC2A-CA77-4FF3-941D-3303E31A09A3 Q35110765-AD74A51C-B727-4A5C-9492-0FEE3783F98B Q35170474-B4165822-23AB-47D8-A8AF-AD8831FD5F04 Q35177449-1165CAA2-C708-412C-AD9C-DB47BBC895CC Q35185685-51C5F5E2-19BB-4172-A677-DA1ED0AC40C5 Q35485880-395DA1CD-3F38-4A2A-A807-57B1B8BF8125 Q35633858-77E3B430-9682-43C3-918D-48692F006344 Q35651735-A65B2E24-3075-448A-A922-AE916A38E47D Q35673530-5B92B444-6733-4661-872D-CE1527DBAD03 Q36055266-FBE30A8C-6FF8-457E-89F6-EAFB6C2048C1 Q36133013-D34C475E-423A-4F9C-AD02-1246CD3E28D3 Q36560134-929C1048-53D0-42E5-8AD8-823CDBDA99F2 Q36592428-169571B6-3BEC-4BBB-A783-FB03FD7C607E Q36596897-6A9D2A22-9C9F-40FE-8A89-9ADDBCA36473 Q36627127-CDFF2F0A-376E-4F8F-9AE0-93E034830516 Q36941032-1ACCCCE2-B05E-49D7-A603-885A48186EE0 Q37041729-F5DCC041-5A31-44EB-95E1-CBE304F9B8E5 Q37239244-538F24D6-C0B0-4739-94D8-476CB644F346 Q37276359-D1607041-7E66-4DC8-B745-78FC4C0181F2 Q37372806-2CC1072E-2E65-4D66-8D40-E28326A2E8C9 Q37381690-D80A7726-BD3F-406A-82DD-1A0BEB2137D2 Q37810113-F2228E12-7025-47E9-AD5D-0B1EEC03DE6F Q38059251-C472FEFB-83CF-4952-A9D6-836DF74AD10C

P2860

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

http://www.wikidata.org/entity/Q36496601

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Peripheral blood grafts from u ...... ease without improved survival

@ast

Peripheral blood grafts from u ...... ease without improved survival

@en

type

label

Peripheral blood grafts from u ...... ease without improved survival

@ast

Peripheral blood grafts from u ...... ease without improved survival

@en

prefLabel

Peripheral blood grafts from u ...... ease without improved survival

@ast

Peripheral blood grafts from u ...... ease without improved survival

@en

P1433

Q36496601-846A56CE-FD25-4251-9945-55F246F2ECCE

P1476

Q36496601-DF67B627-407A-4C57-BD8B-F11D831B94E6

P2093

Q36496601-1B44B078-2AC1-4F28-9F30-C668F414E7D3

Q36496601-23D494F3-BB78-4FA5-A2A4-C7F721663785

Q36496601-45AD3E06-A811-4BF1-94E8-4D2BEDD242F0

Q36496601-4786820C-2AFE-43D2-955E-3AFFF4531318

Q36496601-7489ADDD-26B6-41A5-B445-72D2317E8BC3

Q36496601-AB616095-EB54-4FFB-8F73-71CEFDE5A784

Q36496601-BDF04ADE-B100-4E47-B7DC-DC85CFB141E5

Q36496601-BE3B49E4-70D1-4293-BBC1-8A3050A3A1C8

Q36496601-C3E3BAD1-EA89-48A7-8C9E-444FC3A92F0C

Q36496601-D1B252B4-5E24-4F16-8EC7-72CCBA55ED61

P2860

Q36496601-54553673-CF72-4525-9D1C-4B6B051DE114

Q36496601-64F5CD5B-B55A-49CC-867F-AE63F36DCAF0

Q36496601-8451B253-E78C-4A75-81E1-C40E804FB829

Q36496601-91CA1855-736A-4870-B5D9-B9FB5B367195

Q36496601-9249919E-6970-408C-BCCF-CE16FBDA4FBB

Q36496601-C63F88D2-3794-489D-8ACB-BF619665BA64

P304

Q36496601-69A92202-44DD-4460-A828-6CFA0B6C6C79

P31

Q36496601-A440D8C0-55AC-4CE4-93EC-ABECAF802F36

P356

Q36496601-3C9A7556-7744-4EF7-AA8C-E80BF80553F9

P433

Q36496601-6F6EDDEF-8138-4632-B460-49826C87F5DD

P478

Q36496601-06F8A920-8BE3-405C-9CE5-46EE90C29128

P577

Q36496601-320AA2F5-17A0-468F-B0EC-45CB90A85B2F

P5875

Q36496601-4770F542-F8C4-4625-B996-1500A38668BE

P698

Q36496601-7F67333F-0B35-4F9A-8D86-BC100B83041E

P932

Q36496601-E976AF10-30CC-475F-ADFC-479D8A8D5029

P356

J.BBMT.2007.08.006

P1433

Biology of Blood and Marrow Transplantation

P1476

Peripheral blood grafts from u ...... ease without improved survival

@en

P2093

Adrian P Gee

http://www.w3.org/2001/XMLSchema#string

Brent R Logan

http://www.w3.org/2001/XMLSchema#string

Claudio Anasetti

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisdorf

http://www.w3.org/2001/XMLSchema#string

David Stroncek

http://www.w3.org/2001/XMLSchema#string

Dennis L Confer

http://www.w3.org/2001/XMLSchema#string

John E Wagner

http://www.w3.org/2001/XMLSchema#string

John R Wingard

http://www.w3.org/2001/XMLSchema#string

Mary Eapen

http://www.w3.org/2001/XMLSchema#string

Mary M Horowitz

http://www.w3.org/2001/XMLSchema#string

P2860

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.

1994 Consensus Conference on Acute GVHD Grading

Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.

Quantification of the completeness of follow-up.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

P304

1461-1468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2007.08.006

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5823760

http://www.w3.org/2001/XMLSchema#string

P698

18022576

http://www.w3.org/2001/XMLSchema#string

P932

2267869

http://www.w3.org/2001/XMLSchema#string